Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Y Cahn

Showing results (41-50 of 178) with videos related to

Pageof 18
Sort By:
Bone Marrow Transplantation|May 9, 2000
Cost-effectiveness of CD34+ dose in peripheral blood progenitor cell transplantation for non-Hodgkin's lymphoma patients: a single centre studyS Limat, M C Woronoff-Lemsi, E Deconinck, et al.
Investigational New Drugs|January 1, 1984
Autologous bone marrow transplantation for acute leukemia using transplant chemopurified with metabolite of oxazaphosphorines (ASTA Z 7557, INN mafosfamide). First clinical resultsP Hervé, J Y Cahn, E Plouvier, et al.
Leukemia|April 1, 1994
Variability of the alloreactive T-cell response to human leukemic blastsM Delain, P Tiberghien, E Racadot, et al.
Immunological Reviews|October 1, 1992
Use of monoclonal antibodies in vivo as a therapeutic strategy for alloimmune or autoimmune reactivity: the Besançon experienceP Herve, E Racadot, D Wendling, et al.
Stem Cells (Dayton, Ohio)|October 1, 1993
Peripheral blood stem cell transplantation followed by recombinant alpha interferon for chronic myelogenous leukemia in chronic phase: preliminary resultsJ Reiffers, J Y Cahn, M Montastruc, et al.
Anticancer Research|August 5, 2010
Influence on Busilvex pharmacokinetics of clonazepam compared to previous phenytoin historical dataE Carreras, J Y Cahn, C Puozzo, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1983
High-dose melphalan and autologous bone marrow transplant for relapsed acute leukaemiaD Maraninchi, M Abecasis, J A Gastaut, et al.
Presse Medicale (Paris, France : 1983)|July 13, 1985
[Incidence of veno-occlusive diseases of the liver after bone marrow graft]J Y Cahn, M Flesch, E Plouvier, et al.
Presse Medicale (Paris, France : 1983)|March 31, 1984
[Prevention of graft-versus-host disease. Elimination of T-lymphocytes from bone marrow cells by complement-dependent cytolysis with a combination of pan-T monoclonal antibodies]P Herve, E Racadot, M Flesch, et al.
Presse Medicale (Paris, France : 1983)|April 7, 1984
[Acute leukemias. Intensive treatment followed by a graft of autologous hematopoietic stem cells treated in vitro with an active derivative of cyclophosphamide]P Herve, E Tamayo, J Y Cahn, et al.
Pageof 18

Showing results (41-50 of 178) with videos related to

Sort By:
Pageof 18
Bone Marrow Transplantation|May 9, 2000
Cost-effectiveness of CD34+ dose in peripheral blood progenitor cell transplantation for non-Hodgkin's lymphoma patients: a single centre studyS Limat, M C Woronoff-Lemsi, E Deconinck, et al.
Investigational New Drugs|January 1, 1984
Autologous bone marrow transplantation for acute leukemia using transplant chemopurified with metabolite of oxazaphosphorines (ASTA Z 7557, INN mafosfamide). First clinical resultsP Hervé, J Y Cahn, E Plouvier, et al.
Leukemia|April 1, 1994
Variability of the alloreactive T-cell response to human leukemic blastsM Delain, P Tiberghien, E Racadot, et al.
Immunological Reviews|October 1, 1992
Use of monoclonal antibodies in vivo as a therapeutic strategy for alloimmune or autoimmune reactivity: the Besançon experienceP Herve, E Racadot, D Wendling, et al.
Stem Cells (Dayton, Ohio)|October 1, 1993
Peripheral blood stem cell transplantation followed by recombinant alpha interferon for chronic myelogenous leukemia in chronic phase: preliminary resultsJ Reiffers, J Y Cahn, M Montastruc, et al.
Anticancer Research|August 5, 2010
Influence on Busilvex pharmacokinetics of clonazepam compared to previous phenytoin historical dataE Carreras, J Y Cahn, C Puozzo, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1983
High-dose melphalan and autologous bone marrow transplant for relapsed acute leukaemiaD Maraninchi, M Abecasis, J A Gastaut, et al.
Presse Medicale (Paris, France : 1983)|July 13, 1985
[Incidence of veno-occlusive diseases of the liver after bone marrow graft]J Y Cahn, M Flesch, E Plouvier, et al.
Presse Medicale (Paris, France : 1983)|March 31, 1984
[Prevention of graft-versus-host disease. Elimination of T-lymphocytes from bone marrow cells by complement-dependent cytolysis with a combination of pan-T monoclonal antibodies]P Herve, E Racadot, M Flesch, et al.
Presse Medicale (Paris, France : 1983)|April 7, 1984
[Acute leukemias. Intensive treatment followed by a graft of autologous hematopoietic stem cells treated in vitro with an active derivative of cyclophosphamide]P Herve, E Tamayo, J Y Cahn, et al.
Pageof 18